Stock Performance and Market Context
On 24 Nov 2025, Tarsons Products touched an intraday low of Rs.198.7, representing a decline of 9.12% on the day and underperforming its sector by 4.95%. This price level also marks the lowest point the stock has traded at in its history. The stock has been on a downward trajectory for 16 consecutive sessions, resulting in a cumulative return of -28.35% during this period.
Volatility has been notable, with an intraday volatility of 5.92% calculated from the weighted average price, indicating significant price fluctuations throughout the trading day. Furthermore, the stock is trading below all key moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages, signalling persistent bearish momentum.
In contrast, the broader market has shown resilience. The Sensex opened 88.12 points higher and was trading at 85,343.57, up 0.13% on the day. The index is approaching its 52-week high of 85,801.70, currently just 0.54% away. The Sensex has gained 2.56% over the last three weeks, supported by strong performances from mega-cap stocks and trading above its 50-day and 200-day moving averages.
Only 1% make it here. This Large Cap from the Gems, Jewellery And Watches sector passed our rigorous filters with flying colors. Be among the first few to spot this gem!
- - Highest rated stock selection
- - Multi-parameter screening cleared
- - Large Cap quality pick
Long-Term Performance and Financial Indicators
Over the past year, Tarsons Products has recorded a return of -46.48%, significantly lagging behind the Sensex, which posted a positive return of 7.85% during the same period. The stock’s 52-week high was Rs.465, highlighting the extent of the decline to the current low of Rs.198.7.
Financially, the company has exhibited subdued growth trends. Operating profit has shown a compound annual rate of decline of approximately 18.84% over the last five years. The latest quarterly results for September 2025 reveal a profit after tax (PAT) of Rs.3.32 crore, which is 51.8% lower compared to the average of the previous four quarters.
Return on Capital Employed (ROCE) for the half-year period stands at 6.69%, the lowest recorded, while the debt-to-equity ratio has risen to 0.41 times, the highest in recent periods. Despite these figures, the company maintains a strong ability to service its debt, with an average EBIT to interest coverage ratio of 12.03, indicating adequate earnings relative to interest obligations.
Institutional investor participation has declined, with a reduction of 3.27% in their stake over the previous quarter, leaving them with a collective holding of 5.91%. This shift may reflect a reassessment of the company’s fundamentals by investors with extensive analytical resources.
Consistent Underperformance Relative to Benchmarks
Tarsons Products has consistently underperformed the BSE500 index over the last three annual periods. The stock’s returns have been negative in each of these years, with a cumulative decline of 46.39% in the past 12 months. Profitability has also contracted, with profits falling by approximately 30% over the same timeframe.
Valuation metrics suggest the stock is trading at a discount relative to its peers’ historical averages. The company’s ROCE of 3.9 and an enterprise value to capital employed ratio of 1.5 indicate a fair valuation in the current market context.
Tarsons Products or something better? Our SwitchER feature analyzes this small-cap Healthcare Services stock and recommends superior alternatives based on fundamentals, momentum, and value!
- - SwitchER analysis complete
- - Superior alternatives found
- - Multi-parameter evaluation
Summary of Key Metrics
To summarise, Tarsons Products is currently trading at Rs.198.7, its lowest level in 52 weeks and all-time history. The stock has experienced a 28.35% decline over the last 16 trading days and shows high intraday volatility. The company’s financial indicators reflect subdued profitability and growth, with a PAT decline of over 50% in the latest quarter and a ROCE below 7% for the half-year period.
Institutional holdings have contracted, and the stock continues to trade below all major moving averages, signalling ongoing market pressure. Despite these challenges, the company’s debt servicing capacity remains robust, and valuation metrics suggest the stock is priced below peer averages.
Get 2 full years of MojoOne Premium for only Rs. 12,999. Subscribe for 1 year and we'll add another year FREE. Offer valid for a limited time. Start Saving Now →
